Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer (Q62111048)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer |
clinical trial |
Statements
A Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Keratinocyte Growth Factor (rHuKGF) in Patients With Hematologic Malignancies Undergoing Total Body Irradiation (TBI) and High-Dose Chemotherapy With Autologous Peripheral Blood Progenitor Cell (PBPC) Transplantation (English)
0 references
January 2000
0 references